261 related articles for article (PubMed ID: 20681354)
1. [Treatment of obsessive-compulsive disorder in an adult].
Kähkönen S; Holmberg N
Duodecim; 2010; 126(11):1310-6. PubMed ID: 20681354
[TBL] [Abstract][Full Text] [Related]
2. Obsessive compulsive disorder.
Soomro GM
Clin Evid; 2005 Dec; (14):1270-83. PubMed ID: 16620454
[No Abstract] [Full Text] [Related]
3. Obsessive compulsive disorder.
Soomro GM
Clin Evid; 2004 Jun; (11):1319-34. PubMed ID: 15652061
[No Abstract] [Full Text] [Related]
4. Obsessive compulsive disorder.
Soomro GM
Clin Evid; 2003 Dec; (10):1172-87. PubMed ID: 15555141
[No Abstract] [Full Text] [Related]
5. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment of obsessive-compulsive disorder.
Kellner M
Dialogues Clin Neurosci; 2010; 12(2):187-97. PubMed ID: 20623923
[TBL] [Abstract][Full Text] [Related]
7. Current issues in the pharmacologic management of obsessive compulsive disorder.
Rasmussen SA; Eisen JL; Pato MT
J Clin Psychiatry; 1993 Jun; 54 Suppl():4-9. PubMed ID: 8101187
[TBL] [Abstract][Full Text] [Related]
8. Obsessive-compulsive disorder in Tourette syndrome.
Goodman WK; Storch EA; Geffken GR; Murphy TK
J Child Neurol; 2006 Aug; 21(8):704-14. PubMed ID: 16970872
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
Dold M; Aigner M; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614
[TBL] [Abstract][Full Text] [Related]
10. The use of antipsychotics in obsessive compulsive disorder.
Conti D; Girone N; Boscacci M; Casati L; Cassina N; Cerolini L; Giacovelli L; Viganò C; Conde MM; Cremaschi L; Dell'Osso BM
Hum Psychopharmacol; 2024 May; 39(3):e2893. PubMed ID: 38340275
[TBL] [Abstract][Full Text] [Related]
11. A review of antipsychotics in the treatment of obsessive compulsive disorder.
Fineberg NA; Gale TM; Sivakumaran T
J Psychopharmacol; 2006 Jan; 20(1):97-103. PubMed ID: 16204331
[No Abstract] [Full Text] [Related]
12. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
Kordon A; Zurowski B; Wahl K; Hohagen F
Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636
[TBL] [Abstract][Full Text] [Related]
13. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
14. Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies.
Jenike MA; Rauch SL
J Clin Psychiatry; 1994 Mar; 55 Suppl():11-7. PubMed ID: 7915709
[TBL] [Abstract][Full Text] [Related]
15. Treating obsessive-compulsive disorder. Options include medication, psychotherapy, surgery, and deep brain stimulation.
Harv Ment Health Lett; 2009 Mar; 25(9):4-5. PubMed ID: 19368037
[No Abstract] [Full Text] [Related]
16. [Resistance and refractoriness in obsessive-compulsive disorder].
Ferrão YA; Diniz JB; Lopes AC; Shavitt RG; Greenberg B; Miguel E
Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S66-76. PubMed ID: 18172943
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S
J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958
[TBL] [Abstract][Full Text] [Related]
18. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR
J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
Weiss EL; Potenza MN; McDougle CJ; Epperson CN
J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
[TBL] [Abstract][Full Text] [Related]
20. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
Ressler KJ; Rothbaum BO
JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
